178 related articles for article (PubMed ID: 25705800)
1. The effects of two different doses of hydrocortisone on cognition in patients with secondary adrenal insufficiency--results from a randomized controlled trial.
Werumeus Buning J; Brummelman P; Koerts J; Dullaart RP; van den Berg G; van der Klauw MM; Tucha O; Wolffenbuttel BH; van Beek AP
Psychoneuroendocrinology; 2015 May; 55():36-47. PubMed ID: 25705800
[TBL] [Abstract][Full Text] [Related]
2. Somatosensory function in patients with secondary adrenal insufficiency treated with two different doses of hydrocortisone-Results from a randomized controlled trial.
Werumeus Buning J; Konopka KH; Brummelman P; Koerts J; Dullaart RPF; van den Berg G; van der Klauw MM; Tucha O; Wolffenbuttel BHR; van Beek AP
PLoS One; 2017; 12(7):e0180326. PubMed ID: 28686664
[TBL] [Abstract][Full Text] [Related]
3. Hydrocortisone Dose Influences Pain, Depressive Symptoms and Perceived Health in Adrenal Insufficiency: A Randomized Controlled Trial.
Werumeus Buning J; Brummelman P; Koerts J; Dullaart RP; van den Berg G; van der Klauw MM; Sluiter WJ; Tucha O; Wolffenbuttel BH; van Beek AP
Neuroendocrinology; 2016; 103(6):771-8. PubMed ID: 26646751
[TBL] [Abstract][Full Text] [Related]
4. Effects of Hydrocortisone on the Regulation of Blood Pressure: Results From a Randomized Controlled Trial.
Werumeus Buning J; van Faassen M; Brummelman P; Dullaart RP; van den Berg G; van der Klauw MM; Kerstens MN; Stegeman CA; Muller Kobold AC; Kema IP; Wolffenbuttel BH; van Beek AP
J Clin Endocrinol Metab; 2016 Oct; 101(10):3691-3699. PubMed ID: 27490921
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of oral hydrocortisone - Results and implications from a randomized controlled trial.
Werumeus Buning J; Touw DJ; Brummelman P; Dullaart RPF; van den Berg G; van der Klauw MM; Kamp J; Wolffenbuttel BHR; van Beek AP
Metabolism; 2017 Jun; 71():7-16. PubMed ID: 28521880
[TBL] [Abstract][Full Text] [Related]
6. Hydrocortisone Affects Fatigue and Physical Functioning Through Metabolism of Tryptophan: A Randomized Controlled Trial.
Sorgdrager FJH; Werumeus Buning J; Bos EH; Van Beek AP; Kema IP
J Clin Endocrinol Metab; 2018 Sep; 103(9):3411-3419. PubMed ID: 29982583
[TBL] [Abstract][Full Text] [Related]
7. Effects of short-term nocturnal cortisol replacement on cognitive function and quality of life in patients with primary or secondary adrenal insufficiency: a pilot study.
Harbeck B; Kropp P; Mönig H
Appl Psychophysiol Biofeedback; 2009 Jun; 34(2):113-9. PubMed ID: 19387826
[TBL] [Abstract][Full Text] [Related]
8. Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation.
Johannsson G; Nilsson AG; Bergthorsdottir R; Burman P; Dahlqvist P; Ekman B; Engström BE; Olsson T; Ragnarsson O; Ryberg M; Wahlberg J; Biller BM; Monson JP; Stewart PM; Lennernäs H; Skrtic S
J Clin Endocrinol Metab; 2012 Feb; 97(2):473-81. PubMed ID: 22112807
[TBL] [Abstract][Full Text] [Related]
9. A randomized, double-blind, crossover study comparing two- and four-dose hydrocortisone regimen with regard to quality of life, cortisol and ACTH profiles in patients with primary adrenal insufficiency.
Ekman B; Bachrach-Lindström M; Lindström T; Wahlberg J; Blomgren J; Arnqvist HJ
Clin Endocrinol (Oxf); 2012 Jul; 77(1):18-25. PubMed ID: 22288685
[TBL] [Abstract][Full Text] [Related]
10. Effects of standard glucocorticoid replacement therapies on subjective well-being: a randomized, double-blind, crossover study in patients with secondary adrenal insufficiency.
Benson S; Neumann P; Unger N; Schedlowski M; Mann K; Elsenbruch S; Petersenn S
Eur J Endocrinol; 2012 Nov; 167(5):679-85. PubMed ID: 22930487
[TBL] [Abstract][Full Text] [Related]
11. Influence of hydrocortisone dosage scheme on health-related quality of life in patients with adrenal insufficiency.
Bleicken B; Hahner S; Loeffler M; Ventz M; Decker O; Allolio B; Quinkler M
Clin Endocrinol (Oxf); 2010 Mar; 72(3):297-304. PubMed ID: 19508599
[TBL] [Abstract][Full Text] [Related]
12. Exploring the Impact of Short- and Long-Term Hydrocortisone Replacement on Cognitive Function, Quality of Life and Catecholamine Secretion: A Pilot Study.
Harbeck B; Danneberg S; Rahvar AH; Haas CS; Lehnert H; Kropp P; Mönig H
Appl Psychophysiol Biofeedback; 2016 Sep; 41(3):341-7. PubMed ID: 27170300
[TBL] [Abstract][Full Text] [Related]
13. Achieving a physiological cortisol profile with once-daily dual-release hydrocortisone: a pharmacokinetic study.
Johannsson G; Lennernäs H; Marelli C; Rockich K; Skrtic S
Eur J Endocrinol; 2016 Jul; 175(1):85-93. PubMed ID: 27129362
[TBL] [Abstract][Full Text] [Related]
14. Weight-related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiency.
Mah PM; Jenkins RC; Rostami-Hodjegan A; Newell-Price J; Doane A; Ibbotson V; Tucker GT; Ross RJ
Clin Endocrinol (Oxf); 2004 Sep; 61(3):367-75. PubMed ID: 15355454
[TBL] [Abstract][Full Text] [Related]
15. An observational study on adrenal insufficiency in a French tertiary centre: Real life versus theory.
Castinetti F; Sahnoun M; Albarel F; Morange I; Philippon M; Conte-Devolx B; Brue T
Ann Endocrinol (Paris); 2015 Feb; 76(1):1-8. PubMed ID: 25617904
[TBL] [Abstract][Full Text] [Related]
16. Impaired attention in patients with adrenal insufficiency - Impact of unphysiological therapy.
Blacha AK; Rahvar AH; Flitsch J; van de Loo I; Kropp P; Harbeck B
Steroids; 2021 Mar; 167():108788. PubMed ID: 33412217
[TBL] [Abstract][Full Text] [Related]
17. Corticosteroid after etomidate in critically ill patients: a randomized controlled trial.
Payen JF; Dupuis C; Trouve-Buisson T; Vinclair M; Broux C; Bouzat P; Genty C; Monneret D; Faure P; Chabre O; Bosson JL
Crit Care Med; 2012 Jan; 40(1):29-35. PubMed ID: 21926601
[TBL] [Abstract][Full Text] [Related]
18. Cardiometabolic and psychological effects of dual-release hydrocortisone: a cross-over study.
Dineen R; Martin-Grace J; Ahmed KMS; Frizelle I; Gunness A; Garrahy A; Hannon AM; O'Reilly MW; Smith D; McDermott J; Healy ML; Agha A; Pazderska A; Gibney J; Thompson CJ; Behan LA; Sherlock M
Eur J Endocrinol; 2021 Feb; 184(2):253-265. PubMed ID: 33513125
[TBL] [Abstract][Full Text] [Related]
19. Effect of once-daily, modified-release hydrocortisone versus standard glucocorticoid therapy on metabolism and innate immunity in patients with adrenal insufficiency (DREAM): a single-blind, randomised controlled trial.
Isidori AM; Venneri MA; Graziadio C; Simeoli C; Fiore D; Hasenmajer V; Sbardella E; Gianfrilli D; Pozza C; Pasqualetti P; Morrone S; Santoni A; Naro F; Colao A; Pivonello R; Lenzi A
Lancet Diabetes Endocrinol; 2018 Mar; 6(3):173-185. PubMed ID: 29229498
[TBL] [Abstract][Full Text] [Related]
20. Glucocorticoid Replacement Affects Serum Adiponectin Levels and HDL-C in Patients With Secondary Adrenal Insufficiency.
Hayashi R; Tamada D; Murata M; Kitamura T; Mukai K; Maeda N; Otsuki M; Shimomura I
J Clin Endocrinol Metab; 2019 Dec; 104(12):5814-5822. PubMed ID: 31290981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
